PT UBC Medical Indonesia Tbk (IDX:LABS)

IDX:LABS Revenue

PT UBC Medical Indonesia Tbk had revenue of 55.32B IDR in the quarter ending September 30, 2026, with 13.51% growth. This brings the company's total for the last twelve months to 214.40B, up 21.38% year-over-year. In the year 2025, PT UBC Medical Indonesia Tbk had annual revenue of 199.30B with 34.99% growth. That makes PT UBC Medical Indonesia Tbk the 36,600th largest company in the world by revenue and 647th in Indonesia.

• Revenue (ttm): 214.40B
• Revenue Growth: +21.38%
• P/S Ratio: 2.24
• Revenue / Employee: n/a
• Employees: 54
• Market Cap: 473.40B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Medical Disposable and Consumables 185.56B 93.1%
• Diagnostic and Equipment 13.74B 6.9%

Fiscal year ended Dec 31, 2025 See the full IDX:LABS breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	199.30B	51.66B	34.99%
Dec 31, 2024	147.64B	10.94B	8.00%
Dec 31, 2023	136.70B	43.41B	46.53%
Dec 31, 2022	93.29B	-36.67B	-28.22%
Dec 31, 2021	129.96B	-	-

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error